Amendment No. 1 to Xenogen License Agreement For Real-Time In Vivo Imaging TechnologyXenogen License Agreement for Real-Time in Vivo Imaging Technology • March 16th, 2006 • Gene Logic Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 16th, 2006 Company Industry JurisdictionThis First Amendment to the Xenogen License Agreement For Real-Time In Vivo Imaging Technology, effective November 20, 2004 (the "Agreement”), by and between Xenogen Corporation, with offices at 860 Atlantic Avenue, Alameda, California 94501 (“Xenogen”) and Gene Logic, Inc., a corporation with a principal place of business at 610 Professional Drive, Gaithersburg, Maryland 20879 (“GL”) is effective as of the 19th day of November, 2005 (the "First Amendment Effective Date").